Invention Grant
- Patent Title: Use of natriuretic peptide for treating heart failure
- Patent Title (中): 使用利尿钠肽治疗心力衰竭
-
Application No.: US11400696Application Date: 2006-04-07
-
Publication No.: US07732406B2Publication Date: 2010-06-08
- Inventor: Veselin Mitrovic , Hartmut Lüss , Wolf-Georg Forssmann , Markus Meyer , Klaus Döhler
- Applicant: Veselin Mitrovic , Hartmut Lüss , Wolf-Georg Forssmann , Markus Meyer , Klaus Döhler
- Applicant Address: DE Hannover
- Assignee: CardioPep Pharma GmbH
- Current Assignee: CardioPep Pharma GmbH
- Current Assignee Address: DE Hannover
- Agency: Lowenstein Sandler PC
- Main IPC: A61K38/17
- IPC: A61K38/17
Abstract:
The present invention relates to the use of a natriurectic peptide, such as urodilatin, for treating a patient suffering from heart failure, such as acute decompensated heart failure. Preferably, a composition comprising an effective amount of urodilatin is intravenously administered to the patient continuously through a time period of at least 24 hours and up to 120 hours, preferably at least 48 hours.
Public/Granted literature
- US20060264376A1 Use of natriuretic peptide for treating heart failure Public/Granted day:2006-11-23
Information query
IPC分类:
